Skip to content

Motivational Evaluation and Intervention With Co-Adapt Application for Healthy Ageing

Motivational Evaluation and Intervention With Co-Adapt Application for Healthy Ageing

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05116553
Enrollment
74
Registered
2021-11-11
Start date
2021-11-11
Completion date
2022-01-20
Last updated
2022-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Motivation, Self Efficacy

Keywords

Motivation, Self efficacy

Brief summary

The aim of this study is to identify effective methodologies to help people to improve their awareness of change, motivation, self-confidence and self-efficacy, compliance in behavioral change and psychological well-being.

Detailed description

Subjects involved will have the opportunity to partecipate in a two-weeks course: two SDT (Self Determination Theory) psychological interviews are scheduled (1 per week) to help the participant increase his motivation and awareness about the problem reported during the counseling session. For this purpose, the use of an APP with a CA (Conversational Agent) will be implemented as a support to help people to identify one's thoughts and emotional states as well as increase their awareness about themselves. Test will be administered at the beginning (T1) and at the end of the meetings (T2). Participants will be randomly divided into one of two groups to understand whether APP and CA has a significant impact in increasing motivation and awareness of the need for a pathway with a professional.

Interventions

BEHAVIORALSDT

Standard 2 SDT (Self Determination Theory) psychological interviews.

DEVICEAPP + CA

An APP with a CA (Conversational Agent).

Sponsors

Idego srl
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Pre-intervention test will be administered to the participants (T1) to assess their psychological well-being, motivation, awareness of change, self-confidence and self-efficacy. Participants will be randomly divided into two group: the experimental group will receive the standard 2 Self Determination Theory (SDT) psychological interviews with the support of the APP with the Conversational Agent (CA), while the control group will receive the 2 SDT (Self Determination Theory) psychological interviews. At the end of the pathway post-intervention test (T2) will be administered to the participants with the same questionnaire of the beginning.

Eligibility

Sex/Gender
ALL
Age
50 Years to 67 Years
Healthy volunteers
Yes

Inclusion criteria

* whitecollar * a sufficient level of education to understand study procedures and be able to communicate with site personnel * 50 to 70 years old

Exclusion criteria

\- current use of narcotics or other substances

Design outcomes

Primary

MeasureTime frameDescription
Change in levels of General Self-Efficacy Scale-10 (GSE-10)Up to day 14GSE-10 test is a validated test for the detection of general self efficacy. The total score ranges from 10 to 40. Higher scores mean better outcomes.
Change in levels of Basic Psychological Need Satisfaction and Frustration Scale (BPNSFS)Up to day 14The BPNSFP-24 test is a validated test for the detection of the satisfaction and frustration of the primary needs: autonomy, relatedness and competence (according to SDT Theory). The total score ranges from 24 to 120. Higher scores mean better outcomes.

Secondary

MeasureTime frameDescription
Change of the scales contained in the Depression Anxiety Stress Scales-21 (DASS-21)Up to day 14The DASS-21 test is a validated test for the detection of depression, anxiety and stress. The total score of each subscale ranges from 0 to 42. Higher scores mean worse outcomes.
Change in World Health Organisation-Five Well-Being Index (WHO-5)Up to day 14The WHO-5 test is a validated test for the detection of psychological wellbeing. The total score ranges from 0 to 100. Higher scores mean better outcomes.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026